Rich, Nicole E. http://orcid.org/0000-0003-2740-8818
Parvathaneni, Aarthi
Sen, Ahana
Odewole, Mobolaji
Arroyo, Ana
Mufti, Arjmand R.
Kerr, Thomas A.
Grant, Lafaine
Tujios, Shannan R.
Mayo, Marlyn J.
Lee, William M.
Yang, Ju Dong
Yokoo, Takeshi
Gopal, Purva
Hoshida, Yujin
Zhu, Hao
Yopp, Adam C.
Marrero, Jorge A.
Singal, Amit G.
Funding for this research was provided by:
National Cancer Institute (R01 CA222900, R01 CA237659)
National Center on Minority Health and Health Disparities (R01 MD12565)
Cancer Prevention and Research Institute of Texas (RR180016)
Texas Health Resources (Clinical Scholar Award)
Article History
Received: 19 February 2021
Accepted: 14 April 2021
First Online: 3 May 2021
Declarations
:
: Jorge Marrero has served as a consultant for Glycotest and received research funding from AstraZeneca. Amit Singal has been on advisory boards and served as a consultant for Wako Diagnostics, Roche, Exact Sciences, Glycotest, GRAIL, Bayer, Eisai, BMS, Exelixis, AstraZeneca, Genentech, and TARGET-RWE. Ju Dong Yang has served as a consultant for Exact Sciences, Gilead Sciences, and Eisai. The other authors have no relevant conflicts of interest.